Virtus ETF Advisers’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-360	Closed	-$210K	–	522
2025 Q4	$210K	Buy	+360	New	+$184K	0.1%	227
2025 Q1	–	Sell	-1,156	Closed	-$357K	–	637
2024 Q4	$357K	Sell	1,156 -33	-3%	-$9.28K	0.15%	195
2024 Q3	$252K	Hold	1,189	–	–	0.12%	240
2024 Q2	$333K	Buy	1,189 +821	+223%	+$195K	0.16%	208
2024 Q1	$98.3K	Sell	368 -29	-7%	-$6.83K	0.05%	367
2023 Q4	$91.9K	Buy	397 +9	+2%	+$1.57K	0.06%	398
2023 Q3	$56.7K	Sell	388 -36	-8%	-$6.78K	0.03%	409
2023 Q2	$97.9K	Sell	424 -1,309	-76%	-$355K	0.06%	396
2023 Q1	$420K	Sell	1,733 -666	-28%	-$181K	0.23%	143
2022 Q4	$696K	Buy	2,399 +880	+58%	+$86.1K	0.36%	118
2022 Q3	$99K	Buy	1,519 +15	+1%	+$1.04K	0.04%	421
2022 Q2	$108K	Sell	1,504 -635	-30%	-$46.7K	0.04%	415
2022 Q1	$210K	Sell	2,139 -131	-6%	-$11K	0.09%	194
2021 Q4	$192K	Buy	2,270 +294	+15%	+$24.2K	0.07%	224
2021 Q3	$158K	Sell	1,976 -102	-5%	-$8.81K	0.07%	329
2021 Q2	$202K	Sell	2,078 -402	-16%	-$47.6K	0.08%	339
2021 Q1	$290K	Buy	2,480 +36	+1%	+$4.2K	0.12%	246
2020 Q4	$272K	Sell	2,444 -435	-15%	-$53.2K	0.11%	268
2020 Q3	$342K	Sell	2,879 -408	-12%	-$44.3K	0.18%	191
2020 Q2	$372K	Sell	3,287 -396	-11%	-$38.9K	0.18%	228
2020 Q1	$246K	Sell	3,683 -543	-13%	-$45.2K	0.1%	255
2019 Q4	$385K	Buy	4,226 +1,626	+63%	+$158K	0.06%	272
2019 Q3	$224K	Sell	2,600 -144	-5%	-$13.5K	0.05%	228
2019 Q2	$288K	Buy	+2,744	New	+$294K	0.06%	234
2019 Q1	–	Sell	-2,700	Closed	-$304K	–	213
2018 Q4	$304K	Buy	2,700 +1,122	+71%	+$174K	0.05%	109
2018 Q3	$338K	Sell	1,578 -1,121	-42%	-$281K	0.04%	181
2018 Q2	$755K	Sell	2,699 -6,930	-72%	-$1.22M	0.67%	66
2018 Q1	$1.13M	Buy	9,629 +5,247	+120%	+$648K	0.98%	23
2017 Q4	$402K	Buy	+4,382	New	+$250K	0.5%	52